I’m Eric Hollander, and I am a professor of psychiatry investigating the compounds contained in cannabis for their potential to help autistic individuals improve their disruptive and compulsive behaviors, social communication and quality of life. ...
I am Eric Hollander, professor of psychiatry and behavioral sciences at Albert Einstein College of Medicine in New York City. I'm working with Spectrum, the go-to source for the latest news and analysis about autism research, to answer your questions about cannabis therapies for autism.
I have spent 6 years researching the effects of cannabis and its active ingredients on the brains and behavior of people on the autism spectrum. I am currently focusing on cannabidivarin (CBDV), one of the compounds in cannabis that is non-psychoactive — meaning it does not produce a high. In one study, my colleagues and I are seeing how CBDV can help autistic children and teenagers. In another study, we are administering CBDV to children and young adults who have Prader-Willi syndrome, a genetic condition related to autism. In both cases, we are testing CBDV against a placebo to see whether we can help reduce these individuals’ irritability without some of the negative side effects that come with the psychotropic medications that would normally be prescribed.
Feel free to ask me anything you might want to know about using cannabis and cannabis compounds as autism therapies!
Spectrum Q＆A on cannabis treatments for autism: https://www.spectrumnews.org/opinion/qa-with-eric-hollander-cannabis-treatments-for-autism/
Spectrum’s archival special report on cannabis as an autism therapy: https://www.spectrumnews.org/features/special-reports/special-report-how-cannabis-could-shape-future-autism-therapies/